Related references
Note: Only part of the references are listed.Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
Manabu Ikeda et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Mild to Moderate Alzheimer Dementia with Insufficient Neuropathological Changes
Alberto Serrano-Pozo et al.
ANNALS OF NEUROLOGY (2014)
Suppression of Alzheimer's Disease-Related Phenotypes by Geranylgeranylacetone in Mice
Tatsuya Hoshino et al.
PLOS ONE (2013)
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Ken-Ichiro Tanaka et al.
NATURE COMMUNICATIONS (2013)
Education and Dementia in the Context of the Cognitive Reserve Hypothesis: A Systematic Review with Meta-Analyses and Qualitative Analyses
Xiangfei Meng et al.
PLOS ONE (2012)
Suppression of Alzheimer's Disease-Related Phenotypes by Expression of Heat Shock Protein 70 in Mice
Tatsuya Hoshino et al.
JOURNAL OF NEUROSCIENCE (2011)
Glucose tolerance status and risk of dementia in the community The Hisayama Study
T. Ohara et al.
NEUROLOGY (2011)
Astroglia in dementia and Alzheimer's disease
J. J. Rodriguez et al.
CELL DEATH AND DIFFERENTIATION (2009)
Geranylgeranylacetone Protects against Diclofenac-Induced Gastric and Small Intestinal Mucosal Injuries in Healthy Subjects: A Prospective Randomized Placebo-Controlled Double-Blind Cross-Over Study
Yasumasa Niwa et al.
DIGESTION (2009)
A Role for HSP70 in Protecting against Indomethacin-induced Gastric Lesions
Shintaro Suemasu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
HSP70 Confers Protection against Indomethacin-Induced Lesions of the Small Intestine
Teita Asano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: A randomized, double-blind trial in Japan
Choitsu Sakamoto et al.
DIGESTION (2007)
Voxel-based morphometry to discriminate early Alzheimer's disease from controls
Y Hirata et al.
NEUROSCIENCE LETTERS (2005)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
T Wyss-Coray et al.
NATURE MEDICINE (2001)
Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
RS Doody et al.
ARCHIVES OF NEUROLOGY (2001)
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study
SL Rogers et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
